e-Therapeutics provides update on ETS2101 phase I trial in brain cancer No serious drug-related adverse events after five dose escalation steps; patients to be enrolled at higher dose levels Oxford and Newcastle, UK, 7 J

First Page		Document Content
Date: 2014-06-17 10:21:20 Radiation therapy Metastasis Glioblastoma multiforme Testicular cancer Medicine Brain tumor Glioma		e-Therapeutics provides update on ETS2101 phase I trial in brain cancer No serious drug-related adverse events after five dose escalation steps; patients to be enrolled at higher dose levels Oxford and Newcastle, UK, 7 J Add to Reading List Source URL: etherapeutics.co.uk Download Document from Source Website File Size: 120,96 KB Share Document on Facebook

	www.nnjournal.net Special Issue Brain Tumor Guest Editor: DocID: 1uZFw - View Document
	Answers to Questions You May Have When Your Child Is Diagnosed With a Brain Tumor ™ DocID: 1uU1z - View Document
	Tentative on-site schedule for 16 September 2018 Brain-lesion workshop (BrainLes), Brain Tumor Segmentation (BraTS) Challenge Ischemic Lesion Segmentation (ISLES) Challenge 08:00-10:00 SESSION 1 (BrainLes) DocID: 1uT4p - View Document
	Final on-site schedule for 17. October MICCAI 2016 BrainLes: Brain-lesion workshop (BrainLes) Ischemic Stroke Lesion Segmentation Challenge (ISLES) Brain Tumor Image Segmentation Challenge (BRATS) Mild Traumatic Brain In DocID: 1ubOe - View Document
	Efficient interactive brain tumor segmentation as within-brain kNN classification Mohammad Havaei1 Pierre-Marc Jodoin1,2 Hugo Larochelle1 1 Universit´ 2 Imeka inc. e de Sherbrooke DocID: 1tVzT - View Document